Bio-Rad Labs (BIO) Q4 Revs Beat Views
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $380.03 +0.95%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $2.32, which includes tax gains and does not compare to the analyst estimate of $1.26. Revenue for the quarter came in at $620.4 million versus the consensus estimate of $619.15 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Is the global equity rally broadening? UBS weighs in
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
